About Us
We harness the potential of stem cells and exosomes to set new standards in medical science. Our proprietary platform integrates patented technologies with state-of-the-art infrastructure that strictly adheres to PIC/S GMP standards, ensuring consistent, high-quality production. This commitment goes beyond regulatory compliance—we aim to lead the industry by shaping the future of regenerative medicine.
To support large-scale production and clinical application, YM Regenerative is establishing Taiwan’s first fully automated PIC/S GMP-compliant manufacturing facility dedicated to stem cell- and exosome-derived biologics. Our goal is to build a pharmaceutical-grade regenerative medicine production base that delivers safe, stable, and clinically viable solutions to patients worldwide.